Pharmacotherapy of panic disorder

References

• American Psychiatric AssociationDiagnostic and statistical manual of mental disorders, IVth edn, Text Revision (DSM-IV-TR)2000Washington, DCAmerican Psychiatric Association
   Google Scholar
• AsnisGMHameediFAGoddardAWFluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatientsPsychiatry Res200110311411472786
   PubMed Web of Science ®Google Scholar
• BakishDHooperCLFilteauMJA double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobiaPsychopharmacoly Bull19963213541
   PubMed Web of Science ®Google Scholar
• BakishDSaxenaBMBowenRReversible monoamine oxidase-A inhibitors in panic disorderClin Neuropharmacology1993167782
   PubMed Web of Science ®Google Scholar
• BakkerAvan BalkomAJSpinhovenPSSRIs vs TCAs in the treatment of panic disorder: a meta-analysisActa Psychiatrica Scand20021061637
   PubMed Web of Science ®Google Scholar
• BallengerJCWheadonDESteinerMDouble-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorderAm J Psychiatry199815536429433336
   PubMed Web of Science ®Google Scholar
• BandelowBBehnkeKLenoirSSertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparisonJ Clin Psychiatry2004654051315096081
   PubMed Web of Science ®Google Scholar
• BlackDWWesnerRBowersWA comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorderArch Gen Psychiatry19935044508422221
   PubMed Web of Science ®Google Scholar
• BotellaCVillaHGarcia-PalaciosARivaGBotellaCLégeronPOptaleGThe use of virtual reality in the treatment of panic and agoraphobiaCybertherapy: Internet and virtual reality as assessment and rehabilitation tools for clinical psychology and neuroscience2004aAmsterdamIos Press
   Google Scholar
• BotellaCVillaHGarcia PalaciosAThe use of VR in the treatment of panic disorders and agoraphobiaStud Health Techn Informatics2004b997390
   PubMedGoogle Scholar
• BradwejnJAhokasASteinDJVenlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled studyBr J Psychiatry2005187352916199795
   PubMed Web of Science ®Google Scholar
• BruceSEVasileRGGoismanRMAre benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?Am J Psychiatry200316014323812900305
   PubMed Web of Science ®Google Scholar
• ButlerACChapmanJEFormanEMThe empirical status of cognitive-behavioural therapy: a review of meta-analysesClin Psychol Rev200626173116199119
   PubMed Web of Science ®Google Scholar
• CarlbringPBohmanSBruntSRemote treatment of panic disorder: a randomized trial of internet-based cognitive behavior therapy supplemented with telephone callsAm J Psychiatry200616321192517151163
   PubMed Web of Science ®Google Scholar
• ChouinardGIssues in the clinical use of benzodiazepines: potency, withdrawal, and reboundJ Clin Psychiatry20046571215078112
   PubMed Web of Science ®Google Scholar
• CraskeMGFarchioneTJAllenLBCognitive behavioural therapy for panic disorder and comorbidity: More of the same or less of more?Behav Res Ther200645109510917069753
   PubMed Web of Science ®Google Scholar
• DannonPNIancuICohenAThree year naturalistic outcome study of panic disorder patients treated with paroxetineBMC Psychiatry200441615191617
   PubMed Web of Science ®Google Scholar
• FavaGARuiniCRafanelliCSequential treatment of mood and anxiety disordersJ Clin Psychiatry200566139240016420076
   PubMed Web of Science ®Google Scholar
• FurukawaTAWatanabeNChurchillRPsychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic reviewBr J Psychiatry20061883051216582055
   PubMed Web of Science ®Google Scholar
• GouldRAOttoMWPollackMHA meta-analysis of treatment outcome for panic disorderClin Psychol Review19951581944
   Web of Science ®Google Scholar
• HeldtEGus ManfroGKipperLOne-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remissionBehav Res Therapy20064465765
   PubMed Web of Science ®Google Scholar
• Hoehn-SaricRMcLeodDRHipsleyPAEffect of fluvoxamine on panic disorderJ Clin Psychopharmacology1993133216
   PubMed Web of Science ®Google Scholar
• KampmanMKeijsersGPJHoogduinCALA randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioural therapy aloneJ Clin Psychiatry200263772712363116
   PubMed Web of Science ®Google Scholar
• KatonWRussoJSherbourneCIncremental cost-effectiveness of a collaborative care intervention for panic disorderPsychological Medicine2006363536316403243
   PubMed Web of Science ®Google Scholar
• KesslerRCChiuWTJinRThe epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey ReplicationArch Gen Psychiatry200663415416585471
   PubMed Web of Science ®Google Scholar
• KleinDFDelineation of two drug-responsive anxiety syndromesPsychopharmacologia1964539740814194683
   PubMed Web of Science ®Google Scholar
• KrugerMBDahlAAThe efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorderEur Arch Psych Clin Neurosciences19992491924
   Web of Science ®Google Scholar
• LecrubierYBakkerADunbarGA comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study InvestigatorsActa Psychiatr Scand199795145529065680
   PubMed Web of Science ®Google Scholar
• LecrubierYJudgeRLong-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study InvestigatorsActa Psychiatr Scand199795153609065681
   PubMed Web of Science ®Google Scholar
• LepolaUMWadeAGLeinonenEVA controlled, prospective, 1-year trial of citalopram in the treatment of panic disorderJ Clin Psychiatry199859528349818634
   PubMed Web of Science ®Google Scholar
• LondborgPDWolkowRSmithWTSertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigationBr J Psychiatry199817354609850204
   PubMed Web of Science ®Google Scholar
• MarcusSMGormanJShearMKA comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapyAm J Psychiatry2007164273517267790
   PubMed Web of Science ®Google Scholar
• MavissakalianMRImipramine vs. sertraline in panic disorder: 24-week treatment completersAnn Clin Psychiatry2003151718014971862
   PubMedGoogle Scholar
• MavissakalianMRPerelJMLong-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobiaArch Gen Psychiatry199956821712884888
   PubMed Web of Science ®Google Scholar
• MavissakalianMRPerelJMDuration of imipramine therapy and relapse in panic disorder with agoraphobiaJ Clin Psychopharmacol200222294912006900
   PubMed Web of Science ®Google Scholar
• MichelsonDAllgulanderCDantendorferKEfficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trialBr J Psychiatry2001179514811731354
   PubMed Web of Science ®Google Scholar
• MichelsonDLydiardRBPollackMHOutcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study GroupAm J Psychiatry1998155157079812120
   PubMed Web of Science ®Google Scholar
• MichelsonDPollackMLydiardRBContinuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study GroupBr J Psychiatry1999174213810448445
   PubMed Web of Science ®Google Scholar
• MitteKA meta-analysis of the efficacy of psycho-and pharmacotherapy in panic disorder with and without agoraphobiaJ Affect Disord200588274516005982
   PubMed Web of Science ®Google Scholar
• OehrbergSChristiansenPEBehnkeKParoxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled studyBr J Psychiatry199516737497496647
   PubMed Web of Science ®Google Scholar
• OttoMWPowersMSmitsJASDAdding cognitive-behavioural therapy to pharmacotherapy for panic disorder: issues and strategiesCNS Spectrums20059329
   Web of Science ®Google Scholar
• PohlRBWolkowRMClaryCMSertraline in the treatment of panic disorder: a double-blind multicenter trialAm J Psychiatry19981551189959734541
   PubMed Web of Science ®Google Scholar
• PollackMHLepolaUKoponenHA double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorderDepress Anxiety20072411416894619
   PubMed Web of Science ®Google Scholar
• PollackMHOttoMWWorthingtonJJSertraline in the treatment of panic disorder: a flexible-dose multicenter trialArch Gen Psychiatry1998551010169819070
   PubMed Web of Science ®Google Scholar
• PollackMHSimonNMWorthingtonJJCombined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorderJ Psychopharmacology20031727682
   PubMed Web of Science ®Google Scholar
• PollackMHWorthingtonJJ3rdOttoMWVenlafaxine for panic disorder: results from a double-blind, placebo-controlled studyPsychopharmacol Bull199632667708993089
   PubMed Web of Science ®Google Scholar
• PullCBCottrauxJBerthozARandomized controlled study of virtual reality exposure therapy and cognitive-behaviour therapy in panic disorder with agoraphobiaCyberpsychol Behav20069712
   Google Scholar
• PullCBCurrent status of virtual reality exposure therapy in anxiety disorders: editorial reviewCurr Opin Psychiatry20051871416639177
   PubMed Web of Science ®Google Scholar
• PullCBSelf-help interventions for the treatment of anxiety disordersCurr Opin Psychiatry20061950316612179
   PubMed Web of Science ®Google Scholar
• PullCBCombined pharmacotherapy and cognitive-behavioural therapy for anxiety disordersCurr Opin Psychiatry20072030517143079
   PubMed Web of Science ®Google Scholar
• ResslerKJRothbaumBOTannenbaumLCognitive Enhancers as Adjuncts to Psychotherapy. Use of D-Cycloserine in Phobic Individuals to Facilitate Extinction of FearArch Gen Psychiatry20046111364415520361
   PubMed Web of Science ®Google Scholar
• RickelsKSchweizerEWeissSMaintenance drug treatment for panic disorder. II Short- and long-term outcome after drug taperArch Gen Psychiatry1993506188422223
   PubMed Web of Science ®Google Scholar
• RiedererPLachenmayerLLauxGClinical applications of MAO-inhibitorsCurr Med Chem20041120334315279566
   PubMed Web of Science ®Google Scholar
• RollmanBLBelnapBHMazumdarSA randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary careArch Gen Psychiatry20036213324116330721
   PubMed Web of Science ®Google Scholar
• RosenbaumJFThe development of clonazepam as a psychotropic: the massachusetts general hospital experienceJ Clin Psychiatry2004653615078111
   PubMed Web of Science ®Google Scholar
• Roy-ByrnePPCowleyDSNathanPGormanJMPharmacologic treatment for panic disorder, generalized anxiety disorder, specific phobia and social anxiety disordersA guide to treatments that work2002Second EditionNew YorkOxford University Press33765
   Google Scholar
• Roy-ByrnePPCraskeMGSteinMBA randomized effectiveness trial of cognitive-behavioural therapy and medication for primary care panic disorderArch Gen Psychiatry200562290815753242
   PubMed Web of Science ®Google Scholar
• Roy-ByrnePPCraskeMGSteinMBPanic disorderLancet200636810233216980119
   PubMed Web of Science ®Google Scholar
• SchweizerEPohlRBalonRLorazepam vs. alprazolam in the treatment of panic disorderPharmacopsychiatry1990239032187213
   PubMed Web of Science ®Google Scholar
• SheehanDVBurnhamDBIyengarMKEfficacy and tolerability of controlled-release paroxetine in the treatment of panic disorderJ Clin Psychiatry200566344015669886
   PubMed Web of Science ®Google Scholar
• SheikhJILondborgPClaryCMThe efficacy of sertraline in panic disorder: combined results from two fixed-dose studiesInt Clin Psychopharmacol2000153354211110009
   PubMed Web of Science ®Google Scholar
• StahlSMGergelILiDEscitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trialJ Clin Psychiatry2003641322714658946
   PubMed Web of Science ®Google Scholar
• TillerJWBouwerCBehnkeKMoclobemide and fluoxetine for panic disorder. International Panic Disorder Study GroupEur Arch Psych Clin Neurosciences1999249710
   PubMed Web of Science ®Google Scholar
• ToniCPerugiGFrareFA prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressantsPharmacopsychiatry2000331213110958260
   PubMed Web of Science ®Google Scholar
• Van VlietIMden BoerJAWestenbergHGA double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorderJ Clin Psychopharmacol1996162993068835705
   PubMed Web of Science ®Google Scholar
• VersterJCVolkertsERClinical pharmacology, clinical efficacy, and behavioural toxicity of alprazolam: a review of the literatureCNS Drug Rev200410457614978513
   PubMedGoogle Scholar
• WadeAGLepolaUKoponenHJThe effect of citalopram in panic disorderBr J Psychiatry1997170549539330022
   PubMed Web of Science ®Google Scholar
• WestenDMorrisonKA multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapiesJ Consult Clin Psychol2001698759911777114
   PubMed Web of Science ®Google Scholar